Reckitt vs PayPal
Side-by-side comparison of AI visibility scores, market position, and capabilities
British consumer health company with £14B revenue; Lysol, Mucinex, Nurofen, and Durex brands managing Mead Johnson infant formula litigation while competing with P&G and J&J.
About
Reckitt is a British multinational consumer health and hygiene company producing market-leading brands including Nurofen (ibuprofen), Strepsils, Dettol, Lysol, Durex, Mucinex, Enfamil infant formula, and Woolite — competing across OTC health, hygiene and home, and nutrition categories. Listed on the London Stock Exchange (LSE: RKT) and headquartered in Slough, England, Reckitt generates approximately £14 billion ($17 billion) in annual revenue. The company has undergone significant portfolio reshaping, divesting its Infant Formula & Child Nutrition (IFCN) business in some markets and selling Mead Johnson Nutrition operations.\n\nReckitt's business is organized into two segments: Health (Nurofen, Strepsils, Gaviscon, Mucinex, DayQuil/NyQuil in North America) and Hygiene and Home (Lysol/Dettol disinfectants, Finish dishwasher tablets, Vanish stain remover, Air Wick). The Health segment benefits from strong brand equity in OTC medications that command premium pricing. The Hygiene segment's Lysol brand benefited significantly from COVID-19 disinfectant demand and has sustained elevated brand awareness post-pandemic.\n\nIn 2025, Reckitt faces ongoing challenges from its $2.4 billion acquisition of Mead Johnson (Enfamil) — the company has faced significant litigation related to NEC (necrotizing enterocolitis) lawsuits claiming preterm infant formula contributed to infant deaths, resulting in large court judgments against Reckitt in 2024. The company is managing these legal liabilities while continuing to run its core consumer health and hygiene portfolio. Reckitt competes with Procter & Gamble, Johnson & Johnson, and Haleon for OTC health and hygiene market share. The 2025 strategy focuses on its Power Brands in health and hygiene, cost efficiency, and resolving the Mead Johnson litigation exposure.
San Jose digital payments platform (NASDAQ: PYPL) at $31.8B 2024 revenue processing $1.68T volume across 434M accounts; CEO Chriss AI personalization strategy with Fastlane checkout competing with Stripe and Apple Pay for digital commerce.
About
PayPal Holdings is a San Jose, California-based digital payments technology platform — publicly traded on NASDAQ (NASDAQ: PYPL) at approximately $70 billion market capitalization — providing 434 million active accounts across 200+ markets with digital wallet services (PayPal consumer, Venmo P2P payments), merchant payment processing (PayPal Checkout, Braintree enterprise processing), and buy now pay later (Pay Later). In 2024, PayPal processed $1.68 trillion in total payment volume across 26.3 billion transactions, reporting $31.8 billion in revenue (7% year-over-year growth) and $6.8 billion in free cash flow — with the board authorizing a new $15 billion share repurchase program. Under CEO Alex Chriss (since September 2023), PayPal launched Fastlane (accelerated guest checkout), AI-powered merchant personalization, and PayPal Everywhere (debit card rewards) as new revenue initiatives. Founded in 1998 (as Confinity), spinoff from eBay in 2015.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.